Page last updated: 2024-11-08

alanine and Glycogen Storage Disease Type VII

alanine has been researched along with Glycogen Storage Disease Type VII in 1 studies

Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.

Glycogen Storage Disease Type VII: An autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle (PHOSPHOFRUCTOKINASE-1, MUSCLE TYPE) resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.

Research Excerpts

ExcerptRelevanceReference
"Tarui disease is a glycogen storage disease (GSD VII) and characterized by exercise intolerance with muscle weakness and cramping, mild myopathy, myoglobinuria and compensated hemolysis."1.38Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease. ( Brüser, A; Kirchberger, J; Schöneberg, T, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brüser, A1
Kirchberger, J1
Schöneberg, T1

Other Studies

1 other study available for alanine and Glycogen Storage Disease Type VII

ArticleYear
Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease.
    Biochemical and biophysical research communications, 2012, Oct-12, Volume: 427, Issue:1

    Topics: Alanine; Allosteric Regulation; Animals; Asparagine; Binding Sites; Glycogen Storage Disease Type VI

2012